BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 28276820)

  • 1. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?
    Hasenoehrl C; Storr M; Schicho R
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):329-337. PubMed ID: 28276820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids in the treatment of gasytrointestinal inflammation and symptoms.
    Pesce M; Esposito G; Sarnelli G
    Curr Opin Pharmacol; 2018 Dec; 43():81-86. PubMed ID: 30218940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
    Hryhorowicz S; Kaczmarek-Ryś M; Zielińska A; Scott RJ; Słomski R; Pławski A
    Front Immunol; 2021; 12():790803. PubMed ID: 35003109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
    Ambrose T; Simmons A
    J Crohns Colitis; 2019 Mar; 13(4):525-535. PubMed ID: 30418525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
    O'Brien M; McDougall JJ
    Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of cannabis based treatment in Crohn's disease.
    Naftali T
    Expert Rev Gastroenterol Hepatol; 2020 Apr; 14(4):253-257. PubMed ID: 32149543
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease.
    Liu Y; Wang X; Hu CA
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28832517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Use of Cannabinoids.
    Fraguas-Sánchez AI; Torres-Suárez AI
    Drugs; 2018 Nov; 78(16):1665-1703. PubMed ID: 30374797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
    Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
    Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
    Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
    Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse.
    Carvalho ACA; Souza GA; Marqui SV; Guiguer ÉL; Araújo AC; Rubira CJ; Goulart RA; Flato UAP; Bueno PCDS; Buchaim RL; Barbalho SM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases.
    Kienzl M; Storr M; Schicho R
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00120. PubMed ID: 31899693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].
    Volz MS; Siegmund B; Häuser W
    Schmerz; 2016 Feb; 30(1):37-46. PubMed ID: 26809974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling leukocyte trafficking in IBD.
    Veny M; Fernández-Clotet A; Panés J
    Pharmacol Res; 2020 Sep; 159():105050. PubMed ID: 32598943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
    Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacohistory of Cannabis Use-A New Possibility in Future Drug Development for Gastrointestinal Diseases.
    Thapa D; Warne LN; Falasca M
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.